Literature DB >> 7085610

2'-5'-Linked oligo(adenylic acid) and its analogs. A new class of inhibitors of mRNA methylation.

B B Goswami, R Crea, J H Van Boom, O K Sharma.   

Abstract

Most eukaryotic cellular and viral mRNAs have a blocked, methylated 5' terminus, commonly referred to as a "cap." The 5'-terminal 7-methyl-G in mRNAs is essential for their efficient translation in vitro and may also protect mRNAs against exonucleases. We have explored whether enzymes which synthesize 5' caps of mRNAs are targets for antiviral agents. We have reported earlier that the 5'-triphosphate of a broad spectrum antiviral agent, Ribavirin, and the 5'-mono- and triphosphates of 2'-5'-linked oligo(adenylic acid) (2-5A) synthesized by interferon-treated cells on exposure to double-stranded RNA or EMC virus inhibit in vitro methylation of unmethylated vaccinia RNA by a crude mRNA methylating enzyme system from vaccinia virus. We report here that although 2-5A inhibits both purified vaccinia viral and cellular mRNA (guanine-7-)-methyltransferases at micromolar concentrations, the 3'-O-methylated analogs of 2-5A, methylated in the 3'-terminal-OH or methylated at all three 3'-OH groups and with varying numbers of phosphate groups, specifically inhibited the viral enzyme at submicromolar concentrations. The inhibition is noncompetitive with respect to S-adenosylmethionine, but competitive with respect to mRNA substrate. These compounds are at least 10 times more active than 2-5A. A specific inhibitor of viral mRNA methylation heretofore has not been reported.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7085610

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  pppA2'p5A' blocks vesicular stomatitis virus replication in intact cells.

Authors:  B Alarcon; H Bugany; L Carrasco
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

2.  Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy.

Authors:  James Lara; Guoliang Xia; Mike Purdy; Yury Khudyakov
Journal:  J Virol       Date:  2011-01-19       Impact factor: 5.103

Review 3.  Epistatic connectivity among HCV genomic sites as a genetic marker of interferon resistance.

Authors:  James Lara; Yury Khudyakov
Journal:  Antivir Ther       Date:  2012-12-07

4.  Inhibition of vaccinia virus growth and virus-specific RNA synthesis by 3'-O-methyl adenosine and 3'-O-methyl guanosine.

Authors:  B B Goswami; O K Sharma
Journal:  J Virol       Date:  1983-03       Impact factor: 5.103

5.  Ribavirin reveals a lethal threshold of allowable mutation frequency for Hantaan virus.

Authors:  Dong-Hoon Chung; Yanjie Sun; William B Parker; Jeffrey B Arterburn; Al Bartolucci; Colleen B Jonsson
Journal:  J Virol       Date:  2007-08-15       Impact factor: 5.103

6.  Synthesis of 1-beta-D-ribofuranosyl-3-ethynyl-[1,2,4]triazole and its in vitro and in vivo efficacy against Hantavirus.

Authors:  Dong-Hoon Chung; Sidath C Kumarapperuma; Yanjie Sun; Qianjun Li; Yong-Kyu Chu; Jeffrey B Arterburn; William B Parker; Jeffrey Smith; Kristin Spik; Harish N Ramanathan; Connie S Schmaljohn; Colleen B Jonsson
Journal:  Antiviral Res       Date:  2008-03-17       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.